Probiotics Provide Anti Aging Defense

Scientists report that the strength of your immune system—at least 70% of which is located in your gut—relies on the makeup of your intestinal bacteria.^1,2

Put differently, the estimated 100 trillion bacteria living in your gut are the human equivalent of an environmental ecosystem. And like global ecosystems, our personal microbe population is losing its diversity—and threatening our health as a result.³

Scientists have discovered that disruption of the balance between good and bad bacteria in the gut contributes to the development of chronic conditions such as autoimmune disorders, metabolic syndrome, diabetes, chronic fatigue syndrome, nonalcoholic fatty liver disease, obesity, and more.^4-13

An innovative combination of six critical probiotic strains has been found to rebalance gut flora—powerfully fighting off many of the factors leading to chronic disease.

This combination can be obtained in a dual-encapsulation format that better enables healthy intestinal colonization by protecting the beneficial bacteria from stomach acids that would otherwise destroy them.

Minor Factors Trigger Massive, Long-Term Effects

The delicate balance between beneficial and bad gut bacteria can be disrupted by innumerable factors,^14-27 including the use of antibiotics,^14-16 excessive hygiene,¹⁵ the Western diet,^15-19 modern medical treatments,¹⁸ and obesity.^20-22

As you age, your bacterial population gradually shifts towards a disease-promoting, rather than a disease-preventing state—simply as a result of aging itself!^23-27

Variation in your body’s bacterial makeup has been connected to effects as far-reaching as your individual response to toxins, your metabolic state and degree of insulin resistance, and even your brain development and behavior.^3,14,28

If it seems shocking that such microscopic life forms could control so much of your health destiny, keep in mind their sheer numbers. Your microbes outnumber your body cells by 10 to one,^29,30 and their genes outnumber your own genes by 100 to one.³⁰

In fact, your gut is so jam-packed with bacteria that half of your stool is not leftover food—it’s microbial biomass. And as fast as they’re excreted, these microbes multiply to replenish their numbers.³

How Probiotics Impact The Entire Body

 

So why is it that rebalancing the bacteria in your gut affects areas of the body outside of the intestines? The answer lies in the fact that the intestinal tract contains more chemical detection and signaling molecules than any other organ—and those molecules affect many aspects of health.³¹

Intestinal bacteria produce proteins that have powerful influences on these chemical detectors.³² Over time, an imbalance in the ratio of good-to-bad bacteria activates these many detectors in negative ways that can trigger the development of a host of diseases in many areas of the body—not just those associated with the gut.

Fortunately, probiotic supplements can restore a healthy balance to gut bacteria and reverse these disruptions to intestine-based signaling mechanisms. This, in turn, reverses the negative influence that triggers the development of chronic disease.³³

In other words, probiotics can restore your body’s natural, intestine-based protection against a host of non-intestinal diseases and shield you from the diseases of aging.^4-7,11,18,20

Targeted Probiotics

With advancing technology, scientists have been able to select specific strains of organisms to accomplish precise tasks.³⁴ Evidence now shows that individual species of probiotics within the Lactobacillus genus or the Bifidobacterium genus can powerfully block a variety of pathological factors that lead to different chronic diseases.³⁵

Here are some specific health benefits attributed to each beneficial bacteria species:

• Lactobacillus acidophilus has been shown to decrease the DNA damage that triggers malignant cell development,³⁶
• Lactobacillus rhamnosus improved markers of metabolic syndrome,^37-39
• Lactobacillus paracasei reduced markers of inflammation,⁴⁰
• Bifidobacterium lactis improved blood sugar control,⁴¹
• Bifidobacterium bifidum decreased liver damage,³⁷ and
• Bifidobacterium longum reduced DNA damage that can trigger malignant cell development.⁴²

Experimental models and randomized, controlled human intervention studies have confirmed that taking a probiotic supplement to restore the diverse balance of gut bacteria restores natural protection against multiple diseases.⁴³

Probiotics Strengthen And Modulate Your Immune System

In recent years the enormous importance of the gut bacteria in modulating the immune system has been increasingly recognized. Not only does more than 70% of the human immune system reside in the gut, but the intestinal immune system comprises more antibody-producing cells than the rest of the body put together.⁴⁴ As a result, gastrointestinal secretions are as rich as breast milk in health-supporting and disease-preventing factors.⁴⁵

A poorly functioning immune system is at the root of many chronic degenerative diseases. Too little response makes us vulnerable to the infections that claim the lives of so many older adults. However, inappropriate overactivation can produce chronic inflammation—contributing to a litany of age-related disorders such as diabetes, cancer, and metabolic syndrome.

Using probiotics to help restore the balance of your gut microbiome can strengthen its ability to interact with your immune system in many ways.⁴⁶ These friendly bacteria stimulate healthy immune surveillance, boosting populations of cells that seek out and destroy infecting organisms and cancers.^47-49 They upregulate inflammatory cytokines during the acute stage of an infection or other threat to your body’s integrity—even cancer, as we’ll examine next—but they also contribute to suppression of the inflammatory response as the threat fades.^48,50

What You Need To Know

Probiotics Protect Against Chronic Disease

• Your personal microbial ecosystem may be abundant—providing a home for an estimated 100 trillion bacteria—but it’s losing its diversity, which in turn threatens your health.
• Gut microbiota become unbalanced by an assortment of common factors—gestation duration, Caesarian births, baby formula, antibiotics, excessive hygiene, the Western diet, modern medical treatments, obesity—and even aging itself.
• An increase in the distorted microbial population in the modern human gut correlates with a rise in diseases linked to this imbalance. These include type II diabetes, cancer, Crohn’s disease, ulcerative colitis, celiac disease, nonalcoholic fatty liver disease, gastroenteritis, rheumatoid arthritis, asthma, and allergies.
• It’s difficult to control the factors disrupting your microbial balance, but a range of beneficial, acid-resistant probiotic strains can work together to rebalance your gut. A novel dual-encapsulation format is available that protects them from stomach acids that would otherwise destroy them.

Reducing Cancer With Probiotics

The risk of cancer, especially in the colon, can be reduced through the use of probiotics.⁵¹

One good reason for this is that supplementation with Lactobacillus acidophilus and Bifidobacterium longum significantly decreases the DNA damage that can trigger malignant cell development.³⁶ In addition, replenishing beneficial bacteria with supplements has been found to boost natural antioxidant and detoxification enzymes that prevent the activation of potential dietary carcinogens.^51-53

In one study, when patients with colon cancer and/or with precancerous polyps supplemented with probiotic bacteria, they experienced sharply reduced proliferation of abnormal colon cells and a significant decline in harmful Clostridium bacteria. (In this study, the probiotic was combined with prebiotics, which are substances that feed or promote the accompanying bacteria).⁵⁴

In addition, scientists have demonstrated that probiotic organisms turn on a number of protective signaling mechanisms that play a role in preventing cancer. For instance, probiotics have been documented to:

• Boost populations of immune cells that seek out and destroy cancers,^47-49
• Upregulate inflammatory cytokines during an acute stage of cancer or other threats,^48,50
• Suppress the inflammatory response that could cause tissue or organ damage,^48,50
• Suppress bacteria that convert harmless pro-carcinogen molecules into carcinogens,^48,53
• Bind to potential carcinogens, promoting their excretion,⁵³
• Downregulate an enzyme that converts harmless molecules into carcinogens,⁵³ and
• Stimulate the expression of liver enzymes that detoxify carcinogens.⁵³

Well-Researched Probiotics And Their Specific Anti-Disease Benefits

Numerous factors can unbalance your gut microbiota. As an extreme example, remarkable findings released online by the journal Nature on February 16, 2015, suggest that, just as you can pass certain immune traits along to your children via your own DNA, you may also be passing along immune traits to your offspring via the bacteria in your body.⁸⁶

Probiotics can rebalance the bacterial makeup of your gut. This in turn affects your immunity and your body’s risk of a spectrum of diseases. Scientists continue to add to the list of anti-disease effects attributable to probiotics.

As a broad group, probiotics are commonly associated with their capacity to help prevent or treat:

• Diarrhea (especially following treatment with certain antibiotics)
• Vaginal yeast infections and urinary tract infections
• Irritable bowel syndrome (IBS)
• Certain intestinal infections
• The severity and duration of colds and flu

Improving Diabetes And Metabolic Syndrome

Animal studies as well as human diabetes clinical trials have shown that both Lactobacillus and Bifidobacteria probiotics improve insulin resistance and lead to significant reductions in blood sugar concentrations.^55-57

In a study published in Nutrition journal, patients with type II diabetes consumed a probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis. After six weeks, they experienced significant improvements in fasting glucose and hemoglobin A1c (a measure of long-term blood sugar control). Total antioxidant status also increased.⁵⁴

Reversing Obesity With Probiotics

Studies have shown that there is an association between the overuse of antibiotics and obesity. Research in both animals and humans showed that supplementing with probiotics led to a significant reduction in body weight and body mass index (BMI).^17,58-65

In one study, probiotic supplements were given to mothers prenatally (from about four months before, and six months after, birth). As a result, excessive weight gain was subsequently reduced in the mothers—and in their children from birth right through to 10 years of age!⁶⁶

Human and animal studies show that probiotics also attenuate nonalcoholic fatty liver disease (NAFLD) due to obesity and a high-fat diet.^33,67-71

Enhanced Intestinal Health

Of course, despite the benefits probiotics provide throughout the body, most people still associate the use of probiotics with the improved intestinal health that results directly from higher levels of beneficial bacteria.^72,73

Lactobacillus and Bifidobacteria have been shown to support intestinal function and improve both diarrhea and constipation.^74-76 Probiotic supplements have helped improve the quality of life and symptoms of patients with functional bowel disorders such as irritable bowel syndrome (IBS) and ulcerative colitis, as well as those of generally healthy people.^75,77-79

Helicobacter pylori is a common bacterium infecting about half of the world’s population.⁸⁰ It can cause a diverse spectrum of gastrointestinal disorders, including ulcers. However, due to antibiotic resistance and patient noncompliance, several studies have shown that there is a widespread failure of antibiotic therapy in treating Helicobacter pylori.⁸¹

A meta-analysis of 33 randomized, controlled trials found that several strains of Lactobacillus and one strain of Bifidobacterium—when added to antibiotic therapy—significantly increase H. pylori eradication rates.⁸²

Additionally, probiotics promote the function of the intestinal inner lining, enhancing its ability to act as a barrier to the entry of potentially dangerous organisms and chemicals into the bloodstream.^83-85

Maximizing The Impact Of Probiotics

As beneficial as probiotics are, they have to be able to reach your intestines in order to work—and that requires remaining intact as they pass through the harsh, acidic environment in the stomach. This can limit the number of the live microbes that reach their destination—and in turn, limit their beneficial effects.

Fortunately, a dual-encapsulation technology is available that overcomes this problem by providing a capsule-within-a-capsule. This keeps the capsule that contains the probiotic intact longer to ensure the bacteria reach the small intestine safely. As a result, the probiotic can deliver unprecedented numbers of live colonies to exactly where your body needs them to rebalance your microbiota for critical disease-prevention effects.

It is also important to obtain a variety of bacterial strains that have been shown to deliver comprehensive health benefits.

Experts have recommended supplementation with six potent, complementary, and acid-resistant probiotic strains:

• Lactobacillus acidophilus LA-14
• Lactobacillus rhamnosus LR-32
• Lactobacillus paracasei LPC-37
• Bifidobacterium lactis BL-04
• Bifidobacterium bifidum/lactis BB-02
• Bifidobacterium longum BL-05

A proprietary blend is available that combines all six of these strains with the dual-encapsulation technology that ensures they hit their mark—and powerfully support whole-body health.

The Powerful Role Of Probiotics In Cancer Prevention

As an example of the powerful effects of probiotics, have a look at their inhibitory effects against just one deadly disease: cancer. Scientists have demonstrated that probiotic organisms switch on your body’s protective signaling mechanisms to:

• Suppress bacteria that convert pro-carcinogen molecules into carcinogens,^48,55
• Bind to potential carcinogens, promoting their excretion,⁵⁵
• Decrease enzymes implicated in the development of carcinogens,⁵⁵
• Boost populations of immune cells that play a role in tumor inhibition,^48,87
• Upregulate immune cytokines to battle the early stage of cancer or other threats,⁴⁸ and
• Suppress the inflammatory response as the cancer or infection threat fades.^48,88

Summary

Like the ecosystems around the globe, our personal internal microbe population is losing its diversity and represents a real threat to our long-term health.

From the womb to old age, our gut microbiota can become unbalanced by an array of common factors—gestation duration, Caesarian births, baby formula, antibiotics, excessive hygiene, the Western diet, modern medical treatments, and obesity. And finally, aging gradually shifts our bacterial makeup from a disease-preventing state towards a disease-promoting state!

An increase in diseases is now linked to the increasingly distorted microbial balance in the human gut (known as dysbiosis). These diseases include type II diabetes, cancer, Crohn’s disease, ulcerative colitis, celiac disease, nonalcoholic fatty liver disease, gastroenteritis, rheumatoid arthritis, asthma, and allergies.

Fortunately, a range of probiotic strains, when taken together, can rebalance our gut. And to make sure they reach their destination intact, a novel dual-encapsulation format—a capsule-within-a-capsule—protects them from stomach acids that might otherwise destroy them.

If you have any questions on the scientific content of this article, please call a Life Extension^® Health Advisor at 1-866-864-3027.

References

1. Furness JB, Kunze WA, Clerc N. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am U Physiol. Nov 1999;277(5 Pt 1):G922-8.
2. Khosravi A, Yanez A, Price JG, Chow A, Merad M, Goodridge HS, Mazmanian SK. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe. Mar 12 2014;15(3):374-81.
3. Available at: http://www.nytimes.com/2012/06/14/health/human-microbiome-project-decodes-our-100-trillion-good-bacteria.html?pagewanted=all. Accessed July 16, 2015.
4. Vyas U, Ranganathan N. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract. 2012;2012:872716.
5. Cox LM, Blaser MJ. Pathways in microbe-induced obesity. Cell Metab. 2013 Jun 4;17(6):883-94.
6. Li DY, Yang M, Edwards S, Ye SQ. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):787-93.
7. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):73-83.
8. Knaapen M, Kootte RS, Zoetendal EG, et al. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clin Microbiol Infect. 2013 Apr;19(4):331-7.
9. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010 Jan;26(1):5-11.
10. Sanz Y, Rastmanesh R, Agostonic C. Understanding the role of gut microbes and probiotics in obesity: how far are we? Pharmacol Res. 2013 Mar;69(1):144-55.
11. Mortaz E, Adcock IM, Folkerts G, Barnes PJ, Paul Vos A, Garssen J. Probiotics in the management of lung diseases. Mediators Inflamm. 2013;2013:751068.
12. D’Aversa F, Tortora A, Ianiro G, Ponziani FR, Annicchiarico BE, Gasbarrini A. Gut microbiota and metabolic syndrome. Intern Emerg Med. Apr 2013;8 Suppl 1:S11-5.
13. Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM. Fecal microbiota transplantation broadening its application beyond intestinal disorders. WJG. 2015 Jan 7;21(1):102-11.
14. Dogra S, Sakwinska O, Soh SE,et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio. 2015 Feb 3;6(1).pii: e02419-24.
15. Van den Abbeele P, Verstraete W, El Aidy S, Geirnaert A, Van de Wiele T. Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome. Microb Biotechnol. 2013 Jul;6(4):335-40.
16. Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett. 2005;243:141-7.
17. Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect. 2013 Apr;19(4):305-13.
18. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009 Nov 11;1(6):6ra14.
19. Bengmark S. Nutrition of the critically ill—A 21st-century perspective. Nutrients. 2013 Jan; 5(1):162-207.
20. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 2008 Apr;83(4):460-9.
21. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol. 2009 Dec;9(6):737-43.
22. Lahtinen S, Tiihonen K, Ouwehand AC. Intestinal microbiota and overweight. Benef Microbes. 2010 Nov;1(4):407-21.
23. Candore G, Balistreri CR, Colonna-Romano G, et al. Immunosenescence and anti-immunosenescence therapies: the case of probiotics. Rejuvenation Res. 2008 Apr;11(2):425-32.
24. Guigoz Y, Dore J, Schiffrin EJ. The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):13-20.
25. Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care. 2003 Jan;6(1):49-54.
26. Schiffrin EJ, Morley JE, Donnet-Hughes A, Guigoz Y. The inflammatory status of the elderly: the intestinal contribution. Mutat Res. 2010 Aug 7;690(1-2):50-6.
27. Tiihonen K, Ouwehand AC, Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev. 2010 Apr;9(2):107-16.
28. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012 Nov;10(11):735-42.
29. Simrén M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013 Jan;62(1):159-76.
30. Parfrey LW, Knight R. Spatial and temporal variability of the human microbiota. Clin Microbiol Infec. July 2012;18(4):5-7.
31. Furness JB, Kunze WA, Clerc N. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physiol. 1999 Nov;277(5 Pt 1):G922-8.
32. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology. 2007 Feb;132(2):562-75.
33. Esposito E, Iacono A, Bianco G, et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr. 2009 May;139(5):905-11.
34. O’Hara AM, Shanahan F. Mechanisms of action of probiotics in intestinal diseases. ScientificWorldJournal. 2007;7:31-46.
35. Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr Clin Care. 2004 Apr-Jun;7(2):56-68.
36. Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL. Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br J Nutr. 2004 Jun;91(6):925-32.
37. Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients. 2011 Jun;3(6):637-82.
38. Kim SW, Park KY, Kim B, Kim E, Hyun CK. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochemical Biophysi Re Comm. Feb 8 2013;431(2):258-63.
39. Lee HY, Park JH, Seok SH, et al. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta. 2006 Jul;1761(7):736-44.
40. Bauerl C, Llopis M, Antolin M, et al. Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa. Gene Nutr. 2013 Mar;8(2):165-80.
41. Kim SH, Huh CS, Choi ID, et al. The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo. J Appl Microbiol. Sep 2014;117(3):834-45.
42. Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL. Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Bri J Nutr. Jun 2004;91(6):925-32.
43. De Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1-66.
44. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Mucosal immunity: implications for vaccine development. Immunobiology. 1992 Feb;184(2-3):157-79.
45. Bengmark S. Gut microbial ecology in critical illness: Is there a role for prebiotics, probiotics, and synbiotics? Curr Opin Crit Care. 2002 Apr;8(2):145-51.
46. Rauch M, Lynch S. The potential for probiotic manipulation of the gastrointestinal microbiome. Curr Opin Biotechnol. 2012 Apr;23(2):192-201.
47. Pronio A, Montesani C, Butteroni C, et al. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis. 2008 May;14(5):662-8.
48. De Moreno de LeBlanc A, Matar C, Perdigon G. The application of probiotics in cancer. Br J Nutr. 2007 Oct;98 Suppl 1:S105-10.
49. Makala LH, Suzuki N, Nagasawa H. Peyer’s patches: organized lymphoid structures for the induction of mucosal immune responses in the intestine. Pathobiology. 2002;70(2):55-68.
50. Mencarelli A, Distrutti E, Renga B, et al. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One. 2011;6(7):e22978.
51. Stein K, Borowicki A, Scharlau D, et al. Effects of synbiotic fermentation products on primary chemoprevention in human colon cells. J Nutr Biochem. 2012 Jul;23(7):777-84.
52. Verma A, Shukla G. Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer. 2013;65(1):84-91.
53. Kumar M, Kumar A, Nagpal R, et al. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr. 2010 Aug;61(5):473-96.
54. Rafter J, Bennett M, Caderni G, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007 Feb;85(2):488-96.
55. Esteve E, Ricart W, Fernández-Real JM. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90.
56. Moroti C, Souza Magri LF, de Rezende Costa M, Cavallini DC, Sivieri K. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. 2012;11:29.
57. Hsieh FC, Lee CL, Chai CY, Chen WT, Lu YC, Wu CS. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond). 2013;10(1):35
58. Chang BJ, Park SU, Jang YS, et al. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr. 2011 Nov;65(11):1250-5.
59. Chen JJ, Wang R, Li XF, Wang RL. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med (Maywood). 2011 Jul 1;236(7):823-31.
60. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci. 2011 Jul;94(7):3288-94.
61. Kmar M, Nagpal R, Kumar R, et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012;2012:902917.
62. Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010 Jun;64(6):636-43.
63. Ji YS, Kim HN, Park HJ, et al. Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. Benef Microbes. 2012 Mar 1;3(1):13-22.
64. Park DY, Ahn YT, Park SH, et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 2013;8(3):e59470.
65. Yoo SR, Kim YJ, Park DY, et al. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring). 2013 Dec;21(12):2571-8.
66. Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond). 2010 Oct;34(10):1531-7.
67. Velayudham A, Dolganiuc A, Ellis M, et al. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology. 2009 Mar;49(3):989-97.
68. Aller R, De Luis DA, Izaola O, et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1090-5.
69. Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem. 2011 Aug;22(8):699-711.
70. Zvenigorodskaia LA, Cherkashova EA, Samsonova NG, Nilova TV, Sil’verstova S. Advisability of using probiotics in the treatment of atherogenic dyslipidemia. Eksp Klin Gastroenterol. 2011(2):37-43.
71. Xu RY, Wan YP, Fang QY, Lu W, Cai W. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr. 2012 Jan;50(1):72-7.
72. Sivieri K, Villarreal ML, Adorno MA, Sakamoto IK, Saad SM, Rossi EA. Lactobacillus acidophilus CRL 1014 improved “gut health” in the SHIME(R) reactor. BMC Gastroenterol. 2013 Jun 11;13(1):100.
73. Kaur IP, Kuhad A, Garg A, Chopra K. Probiotics: delineation of prophylactic and therapeutic benefits. J Med Food. 2009 Apr;12(2):219-35.
74. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr. 2009 Feb;101(3):367-75.
75. Buzas GM. Probiotics in gastroenterology—from a different angle. Orv Hetil. 2013 Feb 24;154(8):294-304.
76. Kondo J, Xiao JZ, Shirahata A, et al. Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding. World J Gastroenterol. 2013 Apr 14;19(14):2162-70.
77. Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. Br J Nutr. 2009 Dec;102(11):1654-62.
78. Ringel-Kulka T, Palsson OS, Maier D, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol. 2011 Jul;45(6):518-25.
79. Bixquert Jiménez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig. 2009 Aug;101(8):553-64.
80. Kivi M, Tindberg Y. Helicobacter pylori occurrence and transmission: a family affair? Scand J Infect Dis. 2006;38(6-7):407-17.
81. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. Nov 2006;6(11):699-709.
82. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on helicobacter pylori eradication rates and side effects during eradication therapy: A meta-analysis. PLoS One. 2014;9(11):e111030.
83. Girardin M, Seidman EG. Indications for the use of probiotics in gastrointestinal diseases. Dig Dis. 2011;29(6):574-87.
84. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis. 2008 Nov;14(11):1585-96.
85. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011 May;141(5):769-76.
86. Moon C, Baldridge MT, Wallace MA, Burnham C-AD, Virgin HW, Stappenbeck TS. Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation. Nature. 2015: doi:10.1038/nature14139. Epub: Feb 16, 2015.
87. Soltan Dallal MM, Yazdi MH, Holakuyee M, Hassan ZM, Abolhassani M, Mahdavi M. Lactobacillus casei ssp.casei induced Th1 cytokine profile and natural killer cells activity in invasive ductal carcinoma bearing mice. Iran J Allergy Asthma Immunol. 2012 Jun;11(2):183-9.
88. Magrone T, Jirillo E. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des. 2013;19(7):1329-42.